Company intelligence / Profile preview

Alliance Oncology

Newport Beach, California, USAallianceforclinicaltrialsinoncology.org ↗

Ownership: Private
Development stage: Commercial

Overview

Alliance Oncology operated as a provider of advanced radiation therapy and related oncology services to hospitals and health systems across the United States. The company specialized in comprehensive outpatient oncology solutions and partnered with hospitals to deliver radiation therapy using modern technology. There is no evidence that Alliance Oncology developed drugs or biologics.

Therapeutic areas: Oncology
Industry: Non-Academic Healthcare

Drug pipeline

2 assets

pembrolizumab

Phase 3

Indications: Bladder cancer, Head and neck cancer

1 more asset in the full pipeline.

Request access →

Partnerships

Partnered with U.S. hospitals and health systems

Beyond the preview

Go deeper on Alliance Oncology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alliance Oncology.

Explore the full profile